Literature DB >> 22258242

Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo.

David W Strong1, Larissa B Thackray, Tom J Smith, Herbert W Virgin.   

Abstract

Human noroviruses (HuNoVs) are the major cause of epidemic, nonbacterial gastroenteritis worldwide. Due to the lack of a tractable model system and the inability to grow HuNoVs in cell culture, factors required for the norovirus (NoV) life cycle and pathogenesis in the host remain largely unknown. The discovery of murine norovirus (MNV) and the development of reverse-genetics systems for this virus provide an opportunity to study these aspects of NoV infection in vitro and in vivo. Previous studies identified a single amino acid at residue 296 in the protruding (P) domain of the capsid protein that is responsible for determining the virulence of the MNV clone MNV1.CW1 in 12956/SvEv background STAT1-deficient (STAT1(-/-)) mice. In this report, we identified and characterized another determinant of lethality in the P domain that is necessary and sufficient to determine the replication and pathogenesis of the MNV clones MNV1.CW3 and CR6.STL1 in C57BL/6 background STAT1(-/-) mice. Furthermore, we describe how the role of residue 296 in MNV virulence differs between STAT1(-/-) mouse strains. We also describe potential interactions between subdomains of the P domain, as well as between other virus elements, which facilitate recovery of MNV using a reverse-genetics system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258242      PMCID: PMC3302348          DOI: 10.1128/JVI.07038-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  STAT1-dependent innate immunity to a Norwalk-like virus.

Authors:  Stephanie M Karst; Christiane E Wobus; Margarita Lay; John Davidson; Herbert W Virgin
Journal:  Science       Date:  2003-03-07       Impact factor: 47.728

2.  Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype.

Authors:  Mikael Nilsson; Kjell-Olof Hedlund; Margareta Thorhagen; Göran Larson; Kari Johansen; Anders Ekspong; Lennart Svensson
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns.

Authors:  Pengwei Huang; Tibor Farkas; Séverine Marionneau; Weiming Zhong; Nathalie Ruvoën-Clouet; Ardythe L Morrow; Mekibib Altaye; Larry K Pickering; David S Newburg; Jacques LePendu; Xi Jiang
Journal:  J Infect Dis       Date:  2003-06-12       Impact factor: 5.226

4.  Structural requirements for the assembly of Norwalk virus-like particles.

Authors:  Andrea Bertolotti-Ciarlet; Laura J White; Rong Chen; B V Venkataram Prasad; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

6.  Excess mortality following community-onset norovirus enteritis in the elderly.

Authors:  L Gustavsson; L-M Andersson; M Lindh; J Westin
Journal:  J Hosp Infect       Date:  2011-07-20       Impact factor: 3.926

7.  Norwalk virus open reading frame 3 encodes a minor structural protein.

Authors:  P J Glass; L J White; J M Ball; I Leparc-Goffart; M E Hardy; M K Estes
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor.

Authors:  Karsten Hueffer; John S L Parker; Wendy S Weichert; Rachel E Geisel; Jean-Yves Sgro; Colin R Parrish
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants.

Authors:  Lakshmanan Govindasamy; Karsten Hueffer; Colin R Parrish; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Mechanisms of GII.4 norovirus persistence in human populations.

Authors:  Lisa C Lindesmith; Eric F Donaldson; Anna D Lobue; Jennifer L Cannon; Du-Ping Zheng; Jan Vinje; Ralph S Baric
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  60 in total

1.  Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.

Authors:  Joana Rocha-Pereira; Jana Van Dycke; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Murine Norovirus Infection Induces TH1 Inflammatory Responses to Dietary Antigens.

Authors:  Romain Bouziat; Scott B Biering; Elaine Kouame; Kishan A Sangani; Soowon Kang; Jordan D Ernest; Mukund Varma; Judy J Brown; Kelly Urbanek; Terence S Dermody; Aylwin Ng; Reinhard Hinterleitner; Seungmin Hwang; Bana Jabri
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

3.  Persistence of Systemic Murine Norovirus Is Maintained by Inflammatory Recruitment of Susceptible Myeloid Cells.

Authors:  Jacob A Van Winkle; Bridget A Robinson; A Mack Peters; Lena Li; Ruth V Nouboussi; Matthias Mack; Timothy J Nice
Journal:  Cell Host Microbe       Date:  2018-11-01       Impact factor: 21.023

4.  A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.

Authors:  Sanghyun Lee; Hejun Liu; Craig B Wilen; Zoi E Sychev; Chandni Desai; Barry L Hykes; Robert C Orchard; Broc T McCune; Ki-Wook Kim; Timothy J Nice; Scott A Handley; Megan T Baldridge; Gaya K Amarasinghe; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2019-05-23       Impact factor: 21.023

5.  Tropism for tuft cells determines immune promotion of norovirus pathogenesis.

Authors:  Craig B Wilen; Sanghyun Lee; Leon L Hsieh; Robert C Orchard; Chandni Desai; Barry L Hykes; Michael R McAllaster; Dale R Balce; Taylor Feehley; Jonathan R Brestoff; Christina A Hickey; Christine C Yokoyama; Ya-Ting Wang; Donna A MacDuff; Darren Kreamalmayer; Michael R Howitt; Jessica A Neil; Ken Cadwell; Paul M Allen; Scott A Handley; Menno van Lookeren Campagne; Megan T Baldridge; Herbert W Virgin
Journal:  Science       Date:  2018-04-13       Impact factor: 47.728

6.  Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.

Authors:  Megan T Baldridge; Timothy J Nice; Broc T McCune; Christine C Yokoyama; Amal Kambal; Michael Wheadon; Michael S Diamond; Yulia Ivanova; Maxim Artyomov; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

7.  Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response.

Authors:  Stefan T Peterson; Elizabeth A Kennedy; Pamela H Brigleb; Gwen M Taylor; Kelly Urbanek; Traci L Bricker; Sanghyun Lee; Haina Shin; Terence S Dermody; Adrianus C M Boon; Megan T Baldridge
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

8.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence.

Authors:  Timothy J Nice; David W Strong; Broc T McCune; Calvin S Pohl; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 10.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.